Source: Closing Circle

pharmaspectra: Inflexion has Announced Buyout of Pharmaspectra

Inflexion has announced that it has agreed to acquire Pharmaspectra, a leading global provider of medical affairs data to the pharmaceutical and biotech industry. The investment is being made by Inflexion Enterprise Fund IV, Inflexion's dedicated lower mid‐market fund. Founded in...The post Inflexion has Announced Buyout of Pharmaspectra appeared first on Closing Circle.

Read full article »
Est. Annual Revenue
$5.0-25M
Est. Employees
100-250
Jez Moulding's photo - CEO of pharmaspectra

CEO

Jez Moulding

CEO Approval Rating

80/100

Read more